TA
MYGN icon

Teachers Advisors’s Myriad Genetics MYGN Stock Holding History

Teachers Advisors’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$5.11M Buy
153,896
+6,032
+4% +$184K 0.01% 1414
2018
Q4 		$4.3M Buy
147,864
+20,916
+16% +$752K 0.01% 1401
2018
Q3 		$5.84M Buy
126,948
+2,490
+2% +$111K 0.01% 1364
2018
Q2 		$4.65M Buy
124,458
+6,763
+6% +$228K 0.01% 1465
2018
Q1 		$3.48M Hold
117,695
– – ﹤0.01% 1511
2017
Q4 		$4.04M Buy
117,695
+1,948
+2% +$65.7K 0.01% 1455
2017
Q3 		$4.19M Buy
115,747
+340
+0.3% +$9.7K 0.01% 1439
2017
Q2 		$2.98M Sell
115,407
-1,517
-1% -$32.2K ﹤0.01% 1595
2017
Q1 		$2.25M Buy
116,924
+1,287
+1% +$22.8K ﹤0.01% 1714
2016
Q4 		$1.93M Buy
115,637
+5,051
+5% +$91.4K ﹤0.01% 1801
2016
Q3 		$2.28M Hold
110,586
– – ﹤0.01% 1616
2016
Q2 		$3.38M Sell
110,586
-4,289
-4% -$149K 0.01% 1358
2016
Q1 		$4.3M Buy
114,875
+13,509
+13% +$509K 0.01% 1193
2015
Q4 		$4.38M Sell
101,366
-1,350
-1% -$57K 0.01% 1191
2015
Q3 		$3.85M Hold
102,716
– – 0.01% 1214
2015
Q2 		$3.49M Buy
102,716
+50,101
+95% +$1.7M 0.01% 1333
2015
Q1 		$1.86M Sell
52,615
-2,795
-5% -$100K ﹤0.01% 1695
2014
Q4 		$1.89M Buy
55,410
+6,269
+13% +$222K ﹤0.01% 1677
2014
Q3 		$1.9M Buy
49,141
+830
+2% +$31K ﹤0.01% 1630
2014
Q2 		$1.88M Sell
48,311
-6,303
-12% -$235K ﹤0.01% 1667
2014
Q1 		$1.87M Sell
54,614
-3,278
-6% -$102K ﹤0.01% 1629
2013
Q4 		$1.22M Buy
57,892
+10,335
+22% +$261K ﹤0.01% 1873
2013
Q3 		$1.12M Sell
47,557
-36
-0.1% -$1.02K ﹤0.01% 1857
2013
Q2 		$1.28M Buy
+47,593
New +$1.38M ﹤0.01% 1702

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Teachers Advisors's MYGN Position: Q1 2019 in Review

Teachers Advisors increased its Myriad Genetics (MYGN) stake by 4.1% in Q1 2019, buying an estimated $184K and bringing the position to 153,896 shares worth $5.11M. The position accounts for 0.01% of the portfolio, ranked #1414.

Teachers Advisors first reported a position in MYGN in Q2 2013 and has held it in 24 quarters since. The position peaked at $5.84M in Q3 2018. 262 funds tracked by Wall St. Rank hold MYGN as of Q1 2019.

  • Teachers Advisors held 153,896 shares of Myriad Genetics worth $5.11M as of Q1 2019.
  • Teachers Advisors bought 6,032 Myriad Genetics shares in Q1 2019, an estimated $184K.
  • Myriad Genetics made up 0.01% of Teachers Advisors's portfolio in Q1 2019, its #1414 holding.
  • Teachers Advisors first reported a position in Myriad Genetics in Q2 2013 and has held it in 24 quarters since.
  • Teachers Advisors's Myriad Genetics position peaked at $5.84M in Q3 2018.
  • 262 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.